首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition)
【24h】

Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition)

机译:日本骨质疏松症协会使用骨质周转标志性指南在骨质疏松症的诊断和治疗中的执行摘要(2018年版)

获取原文
获取原文并翻译 | 示例
           

摘要

With the aging of society, the number of osteoporosis-related fractures is increasing. Prevention of osteoporosis and maintenance of the quality of life of osteoporosis patients require early diagnosis, effective treatment, and highly precise treatment monitoring. Although bone biopsy is clinically one of the essential techniques for diagnosis of osteoporosis, it is invasive and difficult to perform in general clinical practice. Bone mineral density measurement is another essential technique available in clinical practice that provides good precision. However, it is not effective for determining the appropriate treatment options or evaluating short-term treatment efficacy. On the other hand, bone turnover markers (BTMs) have gained attention because they provide information that is valuable for both the selection of treatment and short-term monitoring.
机译:随着社会的老化,骨质疏松症相关骨折的数量正在增加。 预防骨质疏松症和维持骨质疏松症患者的生活质量需要早期诊断,有效的治疗和高精度的治疗监测。 虽然骨骼活组织检查是临床上的诊断骨质疏松症的必要技术之一,但在一般临床实践中侵入性且难以表演。 骨密度测量是临床实践中提供的另一种基本技术,可提供良好的精度。 但是,确定适当的治疗方法或评估短期治疗疗效无效。 另一方面,骨质周转标记(BTMS)获得了注意力,因为它们提供了对治疗选择和短期监测的有价值的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号